Investor directory

Green Park & Golf Ventures

Green Park & Golf Ventures is a Dallas-based venture capital firm with a focus on early-stage investments in healthcare technology, SaaS, and consumer health sectors. With over 50 years of operational and financial experience, the firm, led by Clay Heighten, M.D., and Carl Soderstrom, provides strategic solutions, financial backing, and a reliable network to its portfolio companies. Founded after the sale of MedicalEdge Healthcare Group and PhyServe Physician Services to Texas Health Resources in 2011, Green Park & Golf Ventures seeks investment opportunities that offer above-market returns for its investors. The firm, which also has an office in Houston, Texas, is actively looking for opportunities in medical-related start-ups in the North Texas Area, investing between $0.1 million and $1 million in its portfolio companies. With Mr. Garcia, who joined full-time in 2011, the firm continues to pursue new investment opportunities and monitor existing investments in its portfolio.

Focus

Series AScale StageEarly VentureSeed RoundSeries BShow more
http://www.gpgventures.com
http://www.gpgventures.com
http://www.gpgventures.com
http://www.gpgventures.com
http://www.gpgventures.com
http://www.gpgventures.com
http://www.gpgventures.com
https://crunchbase.com/organization/green-park-golf-ventures
https://linkedin.com/company/green-park-&-golf-ventures
https://pitchbook.com/profiles/investor/58725-19
https://twitter.com/gpgventures
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=224227958

JR Garcia

Principal

Clay Heighten

Founding Partner

Carl Soderstrom

Founding Partner

95 past transactions

TangoTab

Series A in 2012
TangoTab, Inc. develops a smartphone application that connects cause-driven consumers with restaurants in a collective aim to end local hunger in the United States. The company offers TangoTab, an application to find nearby restaurants and score exclusive deals when a patron checks in or redeems an offer with a participating restaurant, the cost of a meal is donated to a local food bank. It is compatible with Android and iPhone (iOS). The company was incorporated in 2010 and is based in Dallas, Texas.

My Lasting Legacy, Inc.

Private Placement in 2019
My Lasting Legacy, Inc. designs and develops an application to create professional videos to bring communities’ stories to life. My Lasting Legacy, Inc. was formerly known as My Lasting Legacy, LLC and changed its name to My Lasting Legacy, Inc. in August, 2019. The company was incorporated in 2012 and is based in Allen, Texas.

PuraCath Medical

Series A in 2016
PuraCath Medical is dedicated to improving the quality of life for the dialysis patient by reducing infections related to peritoneal dialysis (PD) and saving time through improved, simplified connection of PD catheters. Their novel, easy-to-use technology intends to provide a safe treatment for patients on PD. While decreasing dependence on patient compliance, the goal is to keep patients well protected and healthy throughout the efficient dialysis process.

Brainspace

Series C in 2013
Brainspace Corporation is a pioneer and recognized leader in helping enterprise clients derive meaning, gain insights and identify human connections in unstructured data. Their unique solutions utilize their patented Brainspace platform and are leading the industry in text analytics, accelerating institutional learning and reinventing how organizations exchange knowledge and expertise. Their customers include the Fortune 500, leading consulting firms, legal service providers, and government agencies. Brainspace was founded in 2005 and is headquartered in Addison, TX, USA.

Channel Medsystems

Series C in 2014
Channel Medsystems, Inc. delivers women’s healthcare technologies for endometrial ablation. The company develops cryothermic technology and streamlined delivery system for female patients and healthcare providers. Its technology integrates cryothermic energy and the user controls into a self-contained and handheld device eliminating the need for a separate control unit or capital equipment. The company was incorporated in 2009 and is based in Emeryville, California.

MicroTransponder

Series E in 2022
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

Simpirica Spine

Series A in 2017
Simpirica Spine was founded in 2006 to develop minimally invasive, flexion-restricting stabilization devices.

Vapogenix

Series B in 2015
Vapogenix, Inc., a clinical stage company, develops non-narcotic analgesics for the treatment of localized pain. The company focuses on a suite of products, including topical analgesics to alleviate pain associated with venipuncture, venous cannulation, and minor dermatological procedures, as well as products for treating wound pain and localized inflammatory. Its products are based on formulated volatile anesthetics. The company was founded in 2006 and is based in Houston, Texas.

Ikonopedia, LLC

Series A in 2013
Ikonopedia is a next-generation breast radiology reporting and patient tracking system. Ikonopedia provides patient letters and a questionnaire in 9 languages and runs on all modern devices and systems including tablets. Our closed-loop system is automated to track and monitor patients to full resolution of all clinical concerns. Clinical reports are clear, consistent, and 100% compliant with the ACR BI-RADS® Atlas 5th Edition. Ikonopedia is MQSA-compliant and offers screening and diagnostic modalities that will improve patient safety and save valuable time for the radiologist and staff.

Make My plate

Angel Round in 2014
Make My Plate is changing the dieting world! They present a visually appealing and fun approach to maintaining a healthy lifestyle. They are connecting the dietary ecosystem, answering the user's nutritional needs on one hand and creating a marketplace for professionals on the other.

Gregor Diagnostics

Seed Round in 2018
Gregor Diagnostics Inc. develops molecular diagnostics screening tests for prostate cancer. It offers a system to maintain biomarker stability in the seminal fluid. Gregor Diagnostics Inc. was founded in 2016 and is based in Madison, Wisconsin.

NovaScan

Convertible Note in 2021
NovaScan, Inc. manufactures and develops cancer detection devices. Its device uses Cole relaxation frequency for cancer detection and stratification. The company offers MarginScan, a device for detecting skin cancers; BiopsyScan, a device enabling breast biopsy; FastScan Probe, a device that detects the presence of breast cancer; as well as electrical mammogram and platform technology for the detection of multiple cancerous conditions. NovaScan, Inc. was formerly known as EPET, LLC. The company was incorporated in 2001 and is based in Chicago, Illinois.

Order Mapper

Seed Round in 2012
Order Mapper Inc. is a Platform as a Service ("PaaS") startup founded in 2009. We make it easy for people to order virtually any physical good or service from almost any business from a mobile device such as a smartphone or tablet. Our cloud-based platform receives, processes, and delivers orders to businesses, providing targeted marketing and promotional opportunities. Our app 'Order Pizza' for iPhone is the largest independent pizza directory on mobile. We’ve fulfilled orders for over 30% of pizzerias in the United States, gaining over 250,000 downloads in the process and placing as one of the Top 100 Lifestyle apps in the App Store. We secured early investment from 500 Startups (Dave McClure) and were recently accepted into Tech Wildcatters (class of Spring 2012), one of the Top 10 business accelerators in the United States. We've been featured on TechCrunch, MacWorld, VentureBeat and Geekwire.

MicroTransponder

Venture Round in 2013
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

Nasseo

Series A in 2014
Nasseo, Inc. operates as a medical device company that manufactures dental and orthopedic implant systems to clinicians/dentists. The company offers its products for patients with poor circulatory issues (diabetics and smokers). It serves customers worldwide. The company was incorporated in 2012 and is based in Peoria, Arizona.

Potrero Medical

Series A in 2016
Potrero Medical, Inc. develops monitoring devices to detect subtle changes in various physiological parameters. Its products provide earlier warnings of sepsis or systemic inflammatory response syndrome and optimizing its treatment by detecting and preventing fluid overload during fluid resuscitation. The company’s products measure intra-abdominal pressure, core body temperature, heart rate, respiratory rate, relative cardiac output, and urine output. Potrero Medical, Inc. was formerly known as Consano Medical, Inc. The Company was founded in 2011 and is based in San Francisco, California.

Thermalin

Series A in 2017
Thermalin hopes to disrupt the $30B insulin/insulin delivery market with a disposable, postage-stamp-sized glucose management system enabled by our first-in-class stabilized, highly concentrated, and ultra-rapid acting insulin. This same new insulin molecule in "ordinary" (U-100) concentration will enable the factory-filling of reservoirs for existing insulin pumps. In addition to this lead program, Thermalin is developing partnerships on no-cold-chain basal and mix insulins and on glucose-responsive insulins.

TheraNova

Venture Round in 2015
TheraNova, LLC, a medical device development company, develops biomedical device technologies. Its technologies include a low frequency induction therapy, a cardiovascular anchor, a dynamic vacuum compression, and the autosterilizing implant. The company’s medical device technologies also include a non-invasive endoscopic obesity therapy, an implantable shunt designed to treat chronic fluid collections, a therapeutic hypothermia technology, a non-invasive incontinence therapy for overactive bladder, and the breast implant. TheraNova, LLC is based in Redwood City, California.

Lantern Pharma

Funding Round in 2015
Lantern Pharma Inc., a clinical stage oncology biotechnology company, focuses on the development of precision oncology therapeutics using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, prostate cancer. The company also develops LP-300 as a combination therapy for female non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers and is from the fulvene class of compounds. The company was incorporated in 2013 and is based in Dallas, Texas.

Dignitana

Venture Round in 2015
Dignitana develops a patented scalp cooling system, DigniCap that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out of ten treated patients were able to retain enough of their hair to eliminate the need for a wig.

Orb Health

Series A in 2016
Orb Health, Inc., a mobile healthcare technology company, provides solutions that enable physicians, employers, clinical laboratories, and individuals to access personalized healthcare services. It offers Collaborative Virtual Care that enables the delivery of reimbursed Medicare services, such as chronic care management and more as a virtual extension of practice without requiring additional staff, new applications, and office space. The company’s Collaborative Virtual Care connects existing EMR with virtual care hub and imprints best practices on its workflow empowering remote providers to deliver care. Orb Health, Inc. was formerly known as Visual Medicine INC. The company was founded in 2011 and is based in Richardson, Texas.

Tractus Corporation

Series A in 2014
TRACTUS addresses the specific need in the healthcare marketplace for a low-cost software and hardware platform for whole breast ultrasound. The combined system uses a unique accessory probe that clips onto standard ultrasound systems and then integrates with a proprietary software suite for reviewing and reporting the whole breast ultrasound scan. Its primary device is the BreastMapper and potentially doubles the discovery of small, treatable breast cancers often missed in dense-breasted women. It was founded in 2012 and is based in Austin, Texas.

Semler Scientific

Post in 2017
Semler Scientific, Inc. is an emerging medical risk-assessment company. Their mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Their first patented and U.S. Food and Drug Administration, or FDA, cleared product, is FloChec®. FloChec is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians for whom it was previously impractical to conduct blood flow measurements. Semler Scientific was founded in Portland, Oregon as an Oregon corporation in August 2007. In March 2012, They converted from an S-Corporation to a C-Corporation and in September 2013, they reincorporated as a Delaware corporation.

Hypergiant

Private Placement in 2018
Hypergiant Industries is the AI industrial complex for leading global enterprises and governments. We help major institutions innovate with breakthrough machine intelligence-driven technology, and make sense of data at the intersection of critical infrastructures through our integrated approach of AI products and services. The solutions, products, and companies Hypergiant Industries create support its customers on their mission to speed beyond norms and realize an exploded potential of the future we were promised through AI.

SendInc

Seed Round in 2013
Sendinc provides a simple way to integrate secure email into your own web and software applications. Sendinc helps your organization achieve and maintain compliance with the growing number of regulations including HIPAA,GLBA, SOX, and PCI-DSS.

ImageVision

Series B in 2014
ImageVision provides social media and multimedia sites the tools to automate the recognition and monetization of their visual content. With Billions of photos and videos shared via social media every day, arguably social media’s greatest asset is its free supply of user-generated and user-shared content. By combining real-time visual recognition technology with artificial intelligence and machine learning, ImageVision provides social media and multimedia sites the tools to automate the recognition and monetization of their visual content to both grow revenue and protect their advertisers' brands. ImageVision’s real-time, Visual Search engine is used by market leaders, such as Apple, Facebook, Photobucket, and Yahoo!, to power image search, brand analytics, ad tailoring, and avoiding issues with objectionable content.

Socrates Health Solutions

Series A in 2013
Socrates Health Solutions, Inc. develops and manufactures diabetes testing devices. It offers Companion, a self-monitoring device for blood glucose reading. The company’s products eliminate insertion of needles and finger pricks for calibration and provides real time information for diabetes management. Its device also generates custom alerts and alarms, and shares blood glucose information that is used as conjection with insulin therapy and communicates with mobile devices to track glucose levels and capturing historical data. Socrates Health Solutions, Inc. was incorporated in 2013 and is based in Dallas, Texas.

Savara

Series B in 2012
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

Ikonopedia, LLC

Series B in 2014
Ikonopedia is a next-generation breast radiology reporting and patient tracking system. Ikonopedia provides patient letters and a questionnaire in 9 languages and runs on all modern devices and systems including tablets. Our closed-loop system is automated to track and monitor patients to full resolution of all clinical concerns. Clinical reports are clear, consistent, and 100% compliant with the ACR BI-RADS® Atlas 5th Edition. Ikonopedia is MQSA-compliant and offers screening and diagnostic modalities that will improve patient safety and save valuable time for the radiologist and staff.

InterVene

Series A in 2015
InterVene, Inc. develops catheter-based therapy to restore valvular competency in patients with chronic venous insufficiency (CVI) in the deep veins. The company was incorporated in 2011 and is based in South San Francisco, California.

Tractus Corporation

Seed Round in 2013
TRACTUS addresses the specific need in the healthcare marketplace for a low-cost software and hardware platform for whole breast ultrasound. The combined system uses a unique accessory probe that clips onto standard ultrasound systems and then integrates with a proprietary software suite for reviewing and reporting the whole breast ultrasound scan. Its primary device is the BreastMapper and potentially doubles the discovery of small, treatable breast cancers often missed in dense-breasted women. It was founded in 2012 and is based in Austin, Texas.

TheraNova

Venture Round in 2016
TheraNova, LLC, a medical device development company, develops biomedical device technologies. Its technologies include a low frequency induction therapy, a cardiovascular anchor, a dynamic vacuum compression, and the autosterilizing implant. The company’s medical device technologies also include a non-invasive endoscopic obesity therapy, an implantable shunt designed to treat chronic fluid collections, a therapeutic hypothermia technology, a non-invasive incontinence therapy for overactive bladder, and the breast implant. TheraNova, LLC is based in Redwood City, California.

MicroTransponder

Venture Round in 2013
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

DxUpClose

Seed Round in 2012
DxUpClose, Inc. is young company developing a point-of-care bacterial diagnostic that will perform an antibiotic sensitivity test in sixty minutes. The product is designed to screen for specific bacteria, regardless if the sample has the targeted bacteria, it will count the bacteria that are there and perform antibiotic sensitivity tests - all within sixty minutes. At the end of the test, the product will securely send a list of effective antibiotics to the Healthcare worker’s email or smartphone, so results can be rapidly interpreted by a physician who can then either write a prescription or ePrescribe the appropriate antibiotic. This will reduce the delay in optimal patient care present today by one to three days. Their device is designed to weigh less than sixteen ounces, fit in a pocket, run on batteries and survive temperature extremes, making it easy to transport while still retaining its diagnostic reliability.

Maui Imaging

Series B in 2013
Maui Imaging, Inc. manufactures multiple aperture ultrasound imaging devices. Maui Imaging, Inc. was incorporated in 2006 and is based in Sunnyvale, California.

MicroTransponder

Series B in 2012
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

Retrotope

Series B in 2015
Retrotope Inc. develops drugs for the treatment of degenerative and intractable diseases. The company develops drugs for the treatment of diseases, such as Parkinson, Alzheimer, mitochondrial myopathies, and retinopathies. It provides RT001, a drug for the treatment of infantile neuroaxonal dystrophy. It also operates an online drug platform to preserve and restore mitochondrial health in degenerative diseases. Retrotope Inc. was incorporated in 2006 and is based in Los Altos, California.

Validic

Series A in 2014
Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina.

Kickbox

Seed Round in 2015
Kickbox, Inc. provides email address verification services. The company was incorporated in 2015 and is based in Dallas, Texas. As of August 25, 2020, Kickbox, Inc. operates as a subsidiary of J2 Global, Inc.

Natural Dental Implants

Series A in 2013
Replicate Dental Technologies is dedicated to developing a solution in changing single tooth replacement with a patented, patient-friendly product that does not require drilling or destroying healthy teeth. It offers a minimally-invasive, patented medical device for replacing teeth. The company was founded in 2009 and is headquartered in Dublin, Ireland.

Hie Electronics

Series A in 2012
Hie Electronics specializes in the development and implementation of dense, Blu-ray multi-tiered optical data storage units and enterprise-class digital video recorders. Their flagship product, the TeraStack Solution, supplies innovative data backup and disaster recovery capabilities, video surveillance file storage, medical data retention, architectural and engineering database file storage, high-speed paper scanning and image processing, and critical e-mail backup and recovery for small, medium, and large enterprises using Blu-ray optical technology.

Prolocor

Seed Round in 2022
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.

Perio Sciences

Venture Round in 2012
Perio Sciences, LLC develops oral healthcare products. It offers dental gels, mouth rinse products, toothpastes, and oral care systems. The company sells and distributes its products through dental professionals, hygienists, specialists, other medical professionals, and medi-spas, as well as online. Perio Sciences, LLC was founded in 2008 and is based in Dallas, Texas.

Orb Health

Seed Round in 2015
Orb Health, Inc., a mobile healthcare technology company, provides solutions that enable physicians, employers, clinical laboratories, and individuals to access personalized healthcare services. It offers Collaborative Virtual Care that enables the delivery of reimbursed Medicare services, such as chronic care management and more as a virtual extension of practice without requiring additional staff, new applications, and office space. The company’s Collaborative Virtual Care connects existing EMR with virtual care hub and imprints best practices on its workflow empowering remote providers to deliver care. Orb Health, Inc. was formerly known as Visual Medicine INC. The company was founded in 2011 and is based in Richardson, Texas.

Genomenon

Series A in 2021
Genomenon, Inc. develops a suite of software tools to prioritize data points for decision-making in genetic diagnoses and discoveries. The company offers GENOMENON, a software solution that allows rapid, automated, and accurate analysis of next-generation sequencing data to speed up discovery work and diagnosis. Its diagnostic and discovery tools enable physicians and researchers to identify disease-causing variants from genomic-sequencing datasets. The company was incorporated in 2014 and is based in Ann Arbor, Michigan.

Worlds

Private Placement in 2020
Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.

Serene Medical

Series A in 2012
Serene Medical Inc. provides neurotoxin-free and long-lasting procedure to inhibit motor nerves. Its NeuBelle system is a medical device for precisely locating a motor nerve and using radio frequency to interrupt the signal pathway of the nerve to the muscles that are controlled by that nerve. The company’s product is used by physicians to treat motor nerves that control facial expression of the forehead, including frown lines. Serene Medical Inc. was founded in 2010 and is headquartered in San Ramon, California.

Worlds

Series A in 2020
Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.

Alto

Series B in 2021
Alto provides on-demand rides using a dedicated fleet of new, safe, and well-maintained vehicles. Each driver is an employee of Alto and is carefully vetted and trained to give members a professional and predictable ride, every time. Alto's elegant apps and in-car technology customize each member's experience each time. In short, members drive everything, except for the car. The company is launching in Dallas, Texas with plans to scale to new US cities in 2019. Alto was founded in 2018 and is headquartered in Dallas, Texas, United States

Empirical Spine

Series B in 2021
Empirical Spine is a developer of a medical stabilization system designed to treat degenerative lumbar spinal disorders. The company's system is a minimally invasive flexion-restricting stabilization device that aids patients suffering from spinal stenosis with grade I degenerative spondylolisthesis, enabling hospitals to have tools for secure spinal surgeries.

SendInc

Seed Round in 2012
Sendinc provides a simple way to integrate secure email into your own web and software applications. Sendinc helps your organization achieve and maintain compliance with the growing number of regulations including HIPAA,GLBA, SOX, and PCI-DSS.

Adient Medical

Series C in 2016
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.

CounterFind

Seed Round in 2017
CounterFind is turnkey technology combining a proprietary filtering formula with industry expertise to recognize, report, and remove all ads marketing counterfeit merchandise on Facebook and all counterfeit product listings on Amazon in real time.

Xclaim Mobile

Convertible Note in 2016
XClaim Mobile, Inc. develops an enterprise-grade mobile offer platform. The company offers Xclaim, a mobile offer platform to streamline users’ move to mobile by enhancing existing digital campaigns. Its software gives users with location-based clean and fast marketing; detects device, location, and wallet type; and customizes their offer to be accepted by Apple Pay, Android Pay, and MS Wallet. The company was incorporated in 2016 and is based in Dallas, Texas.

Noninvasix

Venture Round in 2021
Noninvasix, Inc. develops non-invasive precision oximetry to measure brain oxygenation in preterm babies in the newborn intensive care unit (NICU). Its product allows doctors to monitor oxygen sufficiency within organs without invasive catheters. The company was incorporated in 2007 and is based in Galveston, Texas.

Genomenon

Series B in 2022
Genomenon, Inc. develops a suite of software tools to prioritize data points for decision-making in genetic diagnoses and discoveries. The company offers GENOMENON, a software solution that allows rapid, automated, and accurate analysis of next-generation sequencing data to speed up discovery work and diagnosis. Its diagnostic and discovery tools enable physicians and researchers to identify disease-causing variants from genomic-sequencing datasets. The company was incorporated in 2014 and is based in Ann Arbor, Michigan.

Vapogenix

Series B in 2014
Vapogenix, Inc., a clinical stage company, develops non-narcotic analgesics for the treatment of localized pain. The company focuses on a suite of products, including topical analgesics to alleviate pain associated with venipuncture, venous cannulation, and minor dermatological procedures, as well as products for treating wound pain and localized inflammatory. Its products are based on formulated volatile anesthetics. The company was founded in 2006 and is based in Houston, Texas.

Natural Dental Implants

Series A in 2012
Replicate Dental Technologies is dedicated to developing a solution in changing single tooth replacement with a patented, patient-friendly product that does not require drilling or destroying healthy teeth. It offers a minimally-invasive, patented medical device for replacing teeth. The company was founded in 2009 and is headquartered in Dublin, Ireland.

EdgePoint Power

Seed Round in 2012
Demand Response programs are becoming an integral component of the evolving smart grid infrastructure. Large commercial building owners and operators are beginning to realize new sources of revenue available for their willingness to shed energy load during periods of peak consumption. Tenant comfort remains a primary concern for owners and operators; however, EdgePoint minimizes those concerns by providing a robust solution that ensures compliance with demand response events while maintaining comfort levels.

e-Nicotine Technology

Series A in 2013
e-Nicotine Technology, Inc. is a healthcare company that develops electronic nicotine delivery products to reduce smoking urge. Its devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was incorporated in 2012 and is based in Draper, Utah. As of September 28, 2015, e-Nicotine Technology, Inc. operates as a subsidiary of Fontem Ventures B.V.

Ataia

Seed Round in 2018
Ataia Medical, founded in 2017 by a team of biomedical engineers and critical care physicians, is dedicated to empowering patients with the freedom to speak. They develop novel solutions to help patients communicate who are currently unable to because of hard plastic hospital masks.

Validic

Series B in 2015
Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina.

MicroTransponder

Series C in 2015
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and various neurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues. Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.

Gregor Diagnostics

Private Placement in 2018
Gregor Diagnostics Inc. develops molecular diagnostics screening tests for prostate cancer. It offers a system to maintain biomarker stability in the seminal fluid. Gregor Diagnostics Inc. was founded in 2016 and is based in Madison, Wisconsin.

Supergoop

Series A in 2015
Supergoop, LLC develops sun protection products. Its products include Sun 101, a sunscreen product for ultraviolet (UV) protection. The company also offers sunscreen mousse, serum, CC cream, mineral setting powder, anti-aging eye cream, and lip balm for face; hand cream, sunscreen mousse, mineral sunscreen mist, and body butter for body; and lip balms, lip shield, and sunscreens for kids. Additionally, it also manufactures mineral products and products for travelers. The company sells its products online and through retail stores. Supergoop, LLC was founded in 2007 and is headquartered in San Antonio, Texas.

Savara

Series C in 2014
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

Dignitana

Venture Round in 2016
Dignitana develops a patented scalp cooling system, DigniCap that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out of ten treated patients were able to retain enough of their hair to eliminate the need for a wig.

Ortho Kinematics

Venture Round in 2014
Ortho Kinematics is a spine diagnostics company, provides spine motion analysis and diagnostic services. The company provides information to spine clinicians to assist them in diagnosing and treating back and neck pain. Its solution includes KineGraph Vertebral Motion Analyzer, an automated functional diagnostic test for the spine that uses fluoroscopy to capture the spine in motion, producing patient-specific graphs of the kinematics for each vertebral level. The company was founded in 2006 and is based in Austin, Texas.

Ataia, LLC

Private Placement in 2018
Ataia, LLC, a medical device developer, manufactures a communication system that allows hospital patients to speak with their physicians, caregivers, and families. The company was founded in 2017 and is based in Atlanta, Georgia.

Supergoop

Series A in 2013
Supergoop, LLC develops sun protection products. Its products include Sun 101, a sunscreen product for ultraviolet (UV) protection. The company also offers sunscreen mousse, serum, CC cream, mineral setting powder, anti-aging eye cream, and lip balm for face; hand cream, sunscreen mousse, mineral sunscreen mist, and body butter for body; and lip balms, lip shield, and sunscreens for kids. Additionally, it also manufactures mineral products and products for travelers. The company sells its products online and through retail stores. Supergoop, LLC was founded in 2007 and is headquartered in San Antonio, Texas.

Socrates Health Solutions

Series A in 2014
Socrates Health Solutions, Inc. develops and manufactures diabetes testing devices. It offers Companion, a self-monitoring device for blood glucose reading. The company’s products eliminate insertion of needles and finger pricks for calibration and provides real time information for diabetes management. Its device also generates custom alerts and alarms, and shares blood glucose information that is used as conjection with insulin therapy and communicates with mobile devices to track glucose levels and capturing historical data. Socrates Health Solutions, Inc. was incorporated in 2013 and is based in Dallas, Texas.

Admittance Technologies

Series A in 2015
Admittance Technologies, Inc. develops proprietary software and platform technology for heart failure patients. It develops CardioVol, a volume measurement software and platform technology that interrogates the heart with electric fields using existing pacemaker leads and in real time distinguishes the blood and heart muscle components of these fields. The company was founded in 2010 and is based in Austin, Texas with additional office in San Antonio, Texas.

Silicone Arts Laboratories

Seed Round in 2014
Silicone Arts Laboratories, LLC develops and markets products that enhance physical appearances. It provides AeXP (Anatomical Eye – Experimental), a precise replica of a human eye developed for medical training and medical device testing market; and Dermaflage, a topical scar filler that provides a cosmetic option for concealing recessed scars and skin defects on the face and body without surgery and injections. The company was founded in 2010 and is based in Memphis, Tennessee.

Savara

Series C in 2016
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; Phase IIa development stage for treating nontuberculous mycobacterial (NTM) lung infection; and in Phase IIa development stage for the treatment of NTM lung infection in people living with cystic fibrosis. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III development stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquartered in Austin, Texas.

CancerGene Connect

Seed Round in 2015
CancerGene Connect represents the power of evolving technology in healthcare science. With each generation of improvement, our platform makes significant strides in pedigree generation and risk modeling–bringing increasingly powerful connections to thousands of patients and practices.

Tractus Corporation

Series A in 2013
TRACTUS addresses the specific need in the healthcare marketplace for a low-cost software and hardware platform for whole breast ultrasound. The combined system uses a unique accessory probe that clips onto standard ultrasound systems and then integrates with a proprietary software suite for reviewing and reporting the whole breast ultrasound scan. Its primary device is the BreastMapper and potentially doubles the discovery of small, treatable breast cancers often missed in dense-breasted women. It was founded in 2012 and is based in Austin, Texas.

Ortho Kinematics

Venture Round in 2017
Ortho Kinematics is a spine diagnostics company, provides spine motion analysis and diagnostic services. The company provides information to spine clinicians to assist them in diagnosing and treating back and neck pain. Its solution includes KineGraph Vertebral Motion Analyzer, an automated functional diagnostic test for the spine that uses fluoroscopy to capture the spine in motion, producing patient-specific graphs of the kinematics for each vertebral level. The company was founded in 2006 and is based in Austin, Texas.

Algomedica

Series A in 2015
AlgoMedica, Inc., a medical imaging software company, develops solutions that enable radiologists to take CT scan images using radiation dose. The company offers PixelShine, a server or cloud-based software solution that could consume the CT scan images captured at low dose (10% of the dose used in standard protocol) and uses its image enhancing and noise reduction capability to improve the quality of CT scan images to emulate images taken at standard protocol. Its software technology is based on artificial neural network, which is generalizable to provide software for ultra-low dose CT scan images for other body parts, such as abdomen/pelvis, head, liver, and pediatrics. AlgoMedica, Inc. was incorporated in 2012 and is based in Palo Alto, California.

Meta SaaS

Seed Round in 2017
Meta SaaS, Inc develops and delivers software as a service (SaaS) based vendor management solution for small and medium businesses. It maintains PCI compliance and connects with expense, accounting, and payment vendors to identify and consolidate phantom SaaS into a single dashboard. The company’s solution also tracks contract dates and adjusts its reminders based on total contract value and actual time required per-vendor to make changes. It monitors license utilization across all SaaS vendors at a business and provides reports. Meta SaaS, Inc was incorporated in 2016 and is based in Austin, Texas. As of May 2, 2018, Meta SaaS, Inc operates as a subsidiary of Flexera Software LLC.

AdBm Corp

Series A in 2014
AdBm Technologies is an acoustical engineering company that specializes in developing high-performance, low-cost, and easy-to-deploy noise abatement technology for marine environments. The company focuses on the fields of environmental engineering, marine technology, and mechanical engineering. It was founded in 2012 and headquartered in Austin, Texas.

MobileLutions

Seed Round in 2012
MobileLutions has developed an easy to use application that disables texting while driving in a moving vehicle. MobileLutions solution requires no hardware installation and can be easily downloaded onto most PDAs, including IPhones and Androids. At least 1.6 million crashes each year or 28% of all traffic crashes involve drivers using cell phones and texting (National Safety Council Jan 2011). Three out of five, or 60% of all drivers with cell phones, use them while driving even though 91% of them know it is unsafe to do so (Harris Interactive July 2011).

Vapogenix

Series B in 2013
Vapogenix, Inc., a clinical stage company, develops non-narcotic analgesics for the treatment of localized pain. The company focuses on a suite of products, including topical analgesics to alleviate pain associated with venipuncture, venous cannulation, and minor dermatological procedures, as well as products for treating wound pain and localized inflammatory. Its products are based on formulated volatile anesthetics. The company was founded in 2006 and is based in Houston, Texas.

Cariloop

Seed Round in 2014
Cariloop provides the world’s first fully-integrated, human-powered Caregiver Support Platform to help working caregivers and families plan for and manage the care of their loved ones. The Platform features a HIPAA-compliant, cloud-based application that helps families securely communicate across all devices and store important health, financial, and legal documents while having on-demand access to a dedicated Care Coach who guides the families through the many decisions they make over the length of their caregiving journey.

Prolocor

Convertible Note in 2024
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.

Worlds

Series A in 2023
Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.

Validic

Venture Round in 2022
Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina.

Archeio Technologies

Seed Round in 2016
Archeio Technologies provides a robust application suite for exploration and production companies to leverage across multiple web and mobile platforms to streamline the collection and management of data for petroleum engineers, geologists, land, and regulatory to make better business decisions.

Semler Scientific

Venture Round in 2012
Semler Scientific, Inc. is an emerging medical risk-assessment company. Their mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Their first patented and U.S. Food and Drug Administration, or FDA, cleared product, is FloChec®. FloChec is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians for whom it was previously impractical to conduct blood flow measurements. Semler Scientific was founded in Portland, Oregon as an Oregon corporation in August 2007. In March 2012, They converted from an S-Corporation to a C-Corporation and in September 2013, they reincorporated as a Delaware corporation.

e-Nicotine Technology

Series A in 2014
e-Nicotine Technology, Inc. is a healthcare company that develops electronic nicotine delivery products to reduce smoking urge. Its devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was incorporated in 2012 and is based in Draper, Utah. As of September 28, 2015, e-Nicotine Technology, Inc. operates as a subsidiary of Fontem Ventures B.V.

Ortho Kinematics

Series B in 2011
Ortho Kinematics is a spine diagnostics company, provides spine motion analysis and diagnostic services. The company provides information to spine clinicians to assist them in diagnosing and treating back and neck pain. Its solution includes KineGraph Vertebral Motion Analyzer, an automated functional diagnostic test for the spine that uses fluoroscopy to capture the spine in motion, producing patient-specific graphs of the kinematics for each vertebral level. The company was founded in 2006 and is based in Austin, Texas.